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Critical role for Nef in HIV-1–induced podocyte dedifferentia-
tion. The notable glomerular feature of human immunodefi-
ciency virus (HIV)-associated nephropathy (HIVAN) is the
collapse of the capillary tuft with marked glomerular epithelial
cell hyperplasia. These data suggest a loss of normal podocyte
function, which is associated with a loss of the podocyte differ-
entiation markers, Wilm’s tumor (WT-1), synaptopodin, podo-
calyxin, and common acute lymphoblastic leukemia antigen
(CALLA). We have previously shown that HIV-1 expression
can induce these changes in HIV-1 transgenic mice. To identify
which HIV-1 gene product(s) are responsible for the pheno-
typic changes in podocytes, we created multiple mutated HIV-1
constructs and then pseudotyped them with vesticular stomati-
tis virus glycoprotein (VSVG) envelope to enhance the tropism
of these mutant viruses. In addition to gag/pol, the mutant
viruses lacked one of the following, env, nef, rev, vif, vpr, or vpu.
In addition, we generated single gene expressing pseudotyped
viruses to complement the scanning mutation approach of our
viral parental construct. Murine podocytes were then infected
with one of the viral constructs either lacking or expressing
the various HIV-1 genes. We found that HIV-1 nef was neces-
sary and sufficient for proliferation of podocytes and down-
regulation of synaptopodin and CALLA. These data suggest
that Nef induces many of the changes we observe in HIV
transgenic model and, as a result, this now defines the pathway
for exploration of host responses to HIV-1 infection.
Human immunodeficiency virus (HIV)-associated ne-
phropathy (HIVAN) is the single most common cause
of chronic renal insufficiency in HIV-infected patients.
HIVAN is characterized by collapsing glomerulopathy
and microcystic tubular dilatation. The collapse of glo-
merular capillaries is accompanied by striking hyperpla-
sia of glomerular visceral epithelial cells (podocytes) and
a loss of the podocyte markers Wilm’s tumor (WT-1),
synaptopodin, podocalyxin, and common acute lympho-
blastic leukemia antigen (CALLA) [1–3]. Cyclin kinase
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inhibitors p27 and p57 are decreased, and cyclin A and
Ki-67 are reexpressed in collapsing glomerulopathy [1–4].
These data strongly support the hypothesis that the podo-
cyte loses both its functional and morphologic properties
after HIV-1 infection.
We now have clear evidence that HIV-1 infects podo-
cytes of patients with HIVAN and expression of HIV-1
as a transgene in mice induces collapsing glomerulopathy
[5–7]. HIV-1 is a relatively small virus (10 kb), which
encodes nine different gene products by alternative splic-
ing. Thus, any of these genes alone or in combination
may induce the myriad changes observed in the podo-
cyte. Mapping a complex cellular phenotype to a single
gene or a combination of genes is too complex an under-
taking to accomplish using transgenic approaches. To
define which viral gene is responsible, we isolated podo-
cytes and established an in vitro culture system with
validated markers in attempt to map the viral gene re-
sponsible for the most dramatic changes observed in the
glomerular podocytes in vivo. [8]. We expressed HIV-1
genes from retroviral constructs pseudotyped with vesti-
cular stomatitis virus glycoprotein (VSVG) envelope pro-
tein to expand the tropism and permit efficient transduc-
tion [8]. We found that when we infected podocytes with
our parental noninfectious HIV-1 construct that causes
HIVAN in transgenic mice, HIV-1 induced podocyte
proliferation in vitro [8] similar to the podocyte pheno-
typic changes observed in vivo.
Proliferation and dedifferentiation may be linked, but
an equally plausible hypothesis is that they are distinct
as in polycystic kidney disease [9]. In polycystic kidney
disease, for example, some differentiation markers are
lost but others, like Na,K-ATPase return to a fetal pat-
tern [9]. Thus, the mechanisms responsible for changes
in differentiation markers are often complex. We have
previously demonstrated that Nef is responsible for a
functional change in podocytes in vitro, proliferation and
anchorage independent growth in soft agar [10]. Whether
Nef was also responsible for inducing the phenotypic
changes remained unclear.
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Two mutually exclusive and equally plausible hypoth-
eses emerged. First, HIV-1 induces proliferation through
an action of Nef and the process of proliferation itself
or through an effect of Nef induces secondary changes
in differentiation markers. Alternatively, an entirely dif-
ferent HIV-1 gene product (Tat or Vpr, for example)
could be responsible for altering differentiation genes,
whereas Nef induces proliferation. In this latter model,
the combination of the two HIV-1 genes working in
concert produces the overall disease process. This is a
critically important distinction because the definition of
pathogenic mechanisms requires defining either a path-
way induced by a single gene or a more complex pathway
involving the timing of multiple gene products produced
in the podocyte.
We find that Nef expression alone is sufficient to cause
a loss of several differentiation markers. Results from
these studies help guide future studies to define the
mechanism by which Nef induces both functional and
phenotypic changes in the podocyte in vitro and in vivo.
METHODS
Podocytes
The generation and initial characterization of condi-
tionally immortalized clones of murine podocytes has
been described previously [8]. FVB/N mice were bred
with H-sKb-tsA58 ImmortomiceTM (Charles River Labo-
ratories, Wilmington, MA, USA). Mouse podocytes were
isolated using the interferon-inducible temperature sen-
sitive SV40 T antigen provided in the Immortomouse.
One cell line that expressed the podocyte-specific RNA
for WT-1, synaptopodin, podocalyxin, CR1, and CALLA
was selected for the mapping experiments [8]. The ex-
pression of synaptopodin was also confirmed by immu-
nocytochemistry. At low density, podocytes flattened
and developed prominent processes with spindle-like
projections. Cells were maintained in RPMI 1640 me-
dium containing 10% fetal bovine serum (FBS), 100
U/mL penicillin, 100 g/mL streptomycin, and 2 mmol/L
l-glutamine. To permit immortalized growth, the culture
medium was supplemented with 10 U/mL recombinant
mouse -interferon to induce expression of T antigen,
and cells were cultured at 33C (permissive conditions).
To induce differentiation, cells were cultured on type I
collagen at 37C without -interferon. We confirmed the
degradation of the T antigen under nonpermissive condi-
tions by Western blot analysis.
HIV-1 constructs
HIV-1 constructs were described previously [10, 11].
Briefly, HIV-1 gag/pol-deleted pNL4-3:d1443 [12] was
used as the parental construct in the present study with
the following modifications. A fragment containing the
EGFP gene (from pEGFP-C1; Clontech, Palo Alto, CA,
USA) was inserted at the SphI/MscI gag/pol deletion
site. HIV-1 env and/or accessory genes (nef, rev, vif, vpr,
or vpu) were mutated by inactivating the start codon. In
addition, individual HIV-1 genes (env, nef, vif, vpr, vpu,
or tat) were cloned into pHR-CMV-IRES2-GFP-B
(a gift of Dr. James C. Mulloy, Memorial Sloan Ketter-
ing Cancer Center, New York, NY). Green fluorescent
protein (GFP) expression, however, suggested that ex-
pression levels of env and nef were relatively low in pHR-
CMV-IRES2-GFP-B vector. Therefore, HIV-1 nef was
cloned into the pBabe-puro retroviral expression vector
[13]. All HIV-1 constructs were confirmed by sequencing
and Western blot analysis.
The VSV envelope was used to provide pleiotropism
and high titer virus stocks. Infectious viral supernatants
were produced by transient transfection of 293T cells
using Lipofectamine 2000 (Life Technologies, Rockville,
MD, USA). The HIV-1 gag/pol genes and VSV.G enve-
lope glycoprotein were provided in trans using pCMV
R8.91 and pMD.G plasmids, respectively (gifts of Dr.
Didier Trono, Salk Institute, La Jolla, CA, USA). The
Molony murine leukemia virus gag/pol genes were pro-
vided using the episomal vector pREP8 (Invitrogen, Car-
lsbad, CA, USA) [10]. Depending upon the titer of the
virus, 50% to 80% of cells showed GFP expression at
day 5.
Cell culture of mouse podocytes and RNA isolation
After infection with the various viral constructs, podo-
cytes were cultured under permissive conditions on colla-
gen-coated plates until they reached confluence. Then,
podocytes were cultured under nonpermissive conditions
for 14 days. Total RNA was extracted using Trizol (Life
Technologies).
Northern blot analysis
Probes for Northern blot were generated by reverse
transcription-polymerase chain reaction (RT-PCR) of
RNA isolated from glomeruli of a normal mouse. Probes
were derived from the following published cDNA se-
quences: synaptopodin (Gene Bank accession number,
NM021695, nucleotide positions 642-1343), CALLA
(M81591, 1454-2151), ezrin (X60671, 2039-2680), p21
(U24173, 93-394), p27 (U09968, 138-628), cyclin A
(Z26580, 1035-1740), cyclin E (X75888, 500-1200), Ki-
67 (X82786, 7588-8286), and G3PDH (NM008084, 566-
1017). The cDNA probes were radiolabeled with [32P-]
deoxycytidimine triphosphate (dCTP) by random oligo-
nucleotide priming. Expression levels were quantified by
UN-SCAN-IT (Silk Scientific Corporation, Orem, UT,
USA).
Immunoblotting for cyclin E and p21
Podocytes were washed twice with ice-cold phosphate-
buffered saline (PBS) and then incubated on ice for 5
minutes with lysis buffer containing inhibitors for prote-
ases and protein serine/tyrosine phosphatases. Cells were
scraped and cell lysates were obtained after centrifuga-
tion. After determination of protein concentration, cell
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Fig. 1. Synaptopodin expression in infected
podocytes. (A ) Synaptopodin expression in
podocytes infected with viruses mutated in
env, nef, rev, vif, vpr, or vpu. Podocytes were
infected with HIV-1 pNL4-3 (HIV-1), de-
letion mutant viruses (env, nef, rev,
vif, vpr, vpu), tat single gene construct
(Tat), or vector alone (Vector) virus. More
than 50% of cells showed GFP expression at
day 5. Cells were cultured for 14 days and
total RNA was extracted. The expression of
synaptopodin was analyzed by northern blot.
Blots are representative of repeated experi-
ments. (B ) Northern blots were quantitated
and normalized to G3PDH. The level of ex-
pression relative to Mock control (fold in-
duction) is indicated. Bars represent mean 
SD. (C ) Effect of nef or vif on synapto-
podin expression. Podocytes were infected
with pHR-CMV-IRES2-GFP-B vector (pHR
vector), HIV-1 pNL4-3 (HIV), pBabe-puro
expression vector (pBabe vector), pBabe-
puro/nef (Nef), pHR-CMV-IRES2-GFP-
B/vif (Vif). Cells were cultured for 14 days.
The expression of synaptopodin was analyzed
by Northern blot analysis.
lysates were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to membranes for Western blot. Membranes were
incubated with rabbit polyclonal anticyclin E or anti-p21
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA) at
1:1000 dilution for 1 hour at room temperature, with
secondary antibody for another 1 hour and then revealed
by using chemiluminescence reagents (Amersham Phar-
macia Biotech, Inc., Piscataway, NJ, USA). Western blot
for -actin was used as control.
Cell growth assay
Podocytes infected with pBabe-puro/nef or the empty
pBabe-puro vector were selected in the presence of puro-
mycin (1.5 g/mL) under permissive conditions. To in-
activate T antigen, cells were cultured for 7 days under
nonpermissive conditions without puromycin before they
were plated on collagen-coated 6-well plates at 20,000
cells/well. Podocytes were further cultured for 14 days.
Triplicate wells were trypsinized and counted.
Statistical analysis
The Student t test was used for statistical analysis. All
values were expressed as mean  SD. A P value of less
than 0.05 was considered statistically significant.
RESULTS
Mapping of HIV-1 gene responsible
for dedifferentiation
We have reported that infection of podocytes with the
HIV-1 construct pNL4-3:d1443 induces podocyte prolif-
eration [10]. Since kidneys from HIVAN patients mani-
fest a loss of several markers of podocyte differentiation,
we determined first whether we could replicate these in
vivo changes with in vitro infection of podocytes. There-
fore, conditionally immortalized murine podocytes were
infected with HIV-1 pNL4-3:d1443 and cultured for 14
days. Infection with the pNL4-3:d1443 had a similar ef-
fect on differentiation markers in vitro as that observed
in vivo in the murine model and in human disease. Synap-
topodin, a differentiation-specific actin cytoskeleton-
associated protein, is only expressed by differentiating
podocytes in vitro [14]. Synaptopodin is expressed in
normal podocytes in vivo and is lost in the collapsing
glomerulopathy of HIVAN patients and HIV-1 trans-
genic mice [1, 3]. Therefore, it was used as a marker for
podocyte differentiation. Northern blot analysis revealed
that the expression of synaptopodin was down-regulated
in HIV-1–infected podocytes compared to vector-infected
cells (Fig. 1A). As a result, we utilized the in vitro system to
determine the HIV-1 genes responsible for these changes.
To map the HIV-1 genes responsible for the podocyte
dedifferentiation, stop codons were introduced into the
parental constructs to prevent expression of env, nef,
rev, vif, vpr, or vpu. Because HIV-1 Tat is required for
transcriptional transactivation from the HIV-LTR, it was
not mutated. Instead, tat was cloned into pHR-CMV-
IRES2-GFP-B vector to assess its effects when ex-
pressed alone. Down-regulation of synaptopodin oc-
curred in cells infected with HIV-1 pNL4-3:d1443 and
with viruses with stop codons in env, rev, vpr or vpu,
suggesting that these gene products were not necessary
for synaptopodin inhibition (Fig. 1A). In contrast, only
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Fig. 2. Total number of podocytes infected with nef encoding (Nef) or
empty vector (Vector) viruses. To inactivate T antigen, cells were cul-
tured for 7 days under nonpermissive conditions. Podocytes were plated
on collagen-coated 6-well plates at 20,000 cells/well and were cul-
tured for 7 or 14 days. Triplicate wells were trypsinized and counted.
Bars represent mean  SD.
viruses with a stop codon in vif and nef failed to inhibit
synaptopodin expression (Fig. 1A). The level of gene
expression in viruses deficient in vif was variable between
experiments as gauged by the viral GFP expression (data
not shown). To determine which of the two HIV-1 genes
nef or vif is responsible for decreased expression of sy-
naptopodin, podocytes were infected with single gene
constructs containing either vif or nef. Whereas nef
caused potent downregulation of synaptopodin, vif alone
had no effect on synaptopodin expression (Fig. 1C). Sim-
ilarly when tat was expressed as a single gene construct,
there was no evidence of down-regulation of synapto-
podin. These results demonstrate that nef is necessary
and sufficient for down-regulation of synaptopodin.
Nef promotes proliferation in podocytes
We have shown previously that Nef induces prolifera-
tion and anchorage-independent growth in podocytes at
permissive conditions (33C) [10]. To determine if nef
could induce proliferation at nonpermissive conditions
(37C at which T antigen is lost), nef- or vector-infected
podocytes were cultured under nonpermissive condi-
tions for 7 days to inactivate T antigen. The absence of
T antigen was confirmed by Western blot analysis (data
not shown). Cells were plated on collagen-coated 6-well
plates at 20,000 cells/well, and then cultured for 7 or 14
days. The effect of Nef on podocyte proliferation is
shown in Figure 2. Nef enhanced the proliferation of
podocytes on day 7 (2.5-fold increase) and even more
significantly on day 14 (tenfold increase).
Nef dysregulates podocyte gene expression
To determine whether Nef is responsible for the ob-
served changes in HIV-1–induced gene expression, we
first infected podocytes in vitro with the gag/pol-deleted
HIV-1 used to create the transgenic mouse line. As a
positive control, podocyte markers (synaptopodin, WT-1,
and podocalyxin) were down-regulated in HIV-1 trans-
genic podocytes (data not shown). To confirm that these
effects were the direct result of HIV-1 gene expression
and not of clonal variation, podocytes infected with the
HIV-1 transgene were used in the subsequent studies.
After infection with this construct, synaptopodin, CALLA,
and the cyclin-dependent kinase inhibitors p21 and p27
were down-regulated by Northern blot analysis (Fig.
3A). HIV-1 also decreased the expression of WT-1 and
podocalyxin (data not shown). The expression of mark-
ers of proliferation, including cyclin A, cyclin E, and
Ki-67, was increased in the same podocytes when com-
pared to mock-infected cells (Fig. 3A). Two spliced
forms of cyclin A (2.2 kb and 3.6 kb) and two spliced
forms of CALLA were detected. These changes in gene
expression are similar to what is detected in collapsing
glomerulopathy in vivo [1–4].
To investigate whether Nef alone induced these
changes, we repeated the same studies but infected podo-
cytes with a pBabe-puro/nef virus or vector-control virus.
The expression of synaptopodin and CALLA decreased
in nef-infected podocytes (Fig. 3A). Nef also decreased
ezrin, which is expressed in normal podocytes and dimin-
ishes in an early stage of podocyte injury [15]. The ex-
pression of the cyclin-dependent kinase inhibitors p21
and p27 was decreased, while the expression of Ki-67,
cyclin A, and cyclin E was increased by the presence of
Nef (Fig. 3A). We also determined the cell cycle proteins
cyclin E and p21 by Western blot analysis (Fig. 4). Similar
to the results of Northern blot analysis, cyclin E was
found to be increased and p21 was decreased in nef-
expressing podocytes. Nef had no significant effects on
the expression of WT-1 and podocalyxin (data not shown).
These data indicate that Nef appears to be the major
gene product of HIV-1 that is responsible for the changes
in podocyte proliferation and dedifferentiation as deter-
mined in this in vitro assay system. Whether similar ef-
fects can be determined in vivo remains to be seen.
DISCUSSION
Podocytes are terminally differentiated postmitotic
cells that are thought to lose their ability to proliferate
after nephrogenesis. Since collapsing glomerulopathy ac-
companied by podocytes proliferation is a prominent
feature of HIVAN [1–3], this study was intended to ad-
dress the role of HIV-1 gene expression in inducing pro-
liferation and dedifferentiation of podocytes. Our ability
to mimic the in vivo phenotype [1–3] using the entire
gag/pol-deleted HIV-1 mutant viral construct in an in
vitro infection model suggested to us that we could effec-
tively map the HIV-1 genes responsible. Normal mature
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Fig. 3. Effect of HIV-1 and nef on gene ex-
pression. (A ) Podocytes were infected with
HIV-1 (HIV), mock (Control), nef encoding
(Nef) or empty vector (Control) viruses. Cells
were cultured for 14 days on collagen-coated
plates. Gene expression was analyzed by
Northern blot using probes described in the
Methods section. Blots are representative of
repeated experiments. (B and C ) Northern
blots were quantitated and normalized to
G3PDH. The level of expression relative to
control (fold induction) is indicated. Bars rep-
resent mean  SD. () HIV; () Nef. *P 	
0.05.
Fig. 4. Cyclin E and p21 in nef- or vector-infected podocytes. (A )
Western blot. Cells were cultured for 14 days on collagen-coated plates.
Equal amounts of cell lysates were analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using rabbit poly-
clonal anti-cyclin E antibody or anti-p21 antibody. (B ) Relative optical
density was normalized to -actin. The level of expression relative to
vector (fold induction) is indicated. Bars represent mean  SD of
repeated experiments.
podocytes express cell cycle inhibitory proteins p27 and
p57, whereas they do not express cyclin A and Ki-67
[2, 4]. In contrast, in collapsing glomerulopathy, p27 and
p57 are not expressed, while cyclin A and Ki-67 are
expressed [2, 4]. The loss of cyclin kinase inhibitors and
reexpression of cyclin A was suggested to account for a
reentry of the podocyte into the cell cycle producing
proliferation and loss of structural integrity manifested
by collapsing glomerulopathy [2]. Here, we show that
Nef induces proliferation and up-regulates the expres-
sion of cyclin A and cyclin E. These data suggest that
Nef has an important role in inducing reentry of the
podocyte into the cell cycle and subsequent epithelial
hyperplasia. While we do not address the in vivo situation
directly, the apparent in vitro recapitulation of the in
vivo findings strongly suggest that the podocytes are ca-
pable of dedifferentiating and proliferating in response
to HIV-1 infection.
Nef is a 27–34 kD small protein that has multiple func-
tions. Several publications have reported the direct inter-
action of Nef with Src family kinases, protein kinase
C, mitogen-activated protein kinase, Erk-1, Raf1, PAK,
Vav1, and Vav2 (reviewed in [16]). Nef down-regulates
cell-surface receptors, interferes with signal transduction
pathways, and enhances virion infectivity and viral pro-
duction [16]. Although HIV is not an oncogenic retrovi-
rus, the ability of Nef to transform a variety of cell lines
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has been reported. For example, expression of Nef in
astrocytes induced colony formation in soft agar [17].
Nef transgenic mice in which Nef is expressed exclusively
in the skin spontaneously developed epidermal hyper-
plasia [18]. Coexpression of Nef and Hck in rat fibro-
blasts causes a loss of contact inhibition [19]. Previously,
we have shown that Nef induces loss of contact inhibition
of podocytes that results in focus formation in soft agar
[10]. In the current study, we show that Nef suppresses
the expression of mature podocyte markers, including
synaptopodin, CALLA, and ezrin. This effect seems to
be independent of T antigen expression.
Conaldi et al [20] have recently reported that recombi-
nant HIV-1 Tat protein causes podocyte proliferation
and the down-regulation of synaptopodin. In our prelimi-
nary study, we found that Tat had a modest effect on
the growth of podocytes; however, Tat did not induce
down-regulation of synaptopodin, CALLA, podoca-
lyxin, and WT-1 (data not shown). The inability of Tat
to induce dedifferentiation in our system may be due to
lower expression levels as compared to the study by
Conaldi et al [20] who added 1 to 125 ng/mL of Tat
protein to media. In addition, the effects of Tat as an
extracellular protein may be very different from the levels
that are expressed intracellularly. But, we have reported
a minimal ability of Tat to induce colony formation that
can be greatly stimulated when Nef is coexpressed with
Tat in podocytes [10]. These data suggest that both Nef
and Tat may have synergic effects on podocyte prolifera-
tion and dedifferentiation.
Increasing evidence suggests that HIV-1 associated
nephropathy is due to HIV-1 expression in kidney cells
directly. HIV-1 has been detected in glomerular podo-
cytes and in renal tubular epithelial cells in HIVAN
patients [5–7]. We have previously reported the develop-
ment of a HIVAN phenotype in transgenic mice con-
taining the HIV-1 provirus, which is deleted for gag/pol
[21]. These mice do not produce infectious virus, yet
express HIV envelope and regulatory genes, which is
sufficient to recreate morphologic changes in the kidney
that are identical to the disease in humans [21]. In this
murine model, both podocytes and renal tubular epithe-
lial cells express HIV-1 genes [5]. We transplanted kid-
neys from transgenic mice into nontransgenic litter-
mates, while transgenic mice were transplanted with
normal kidneys [12]. Interestingly, HIVAN developed
only in transgenic kidneys transplanted into the nontrans-
genic mice, providing direct evidence that expression of
HIV-1 genes in kidney is sufficient for the development
of HIVAN [12]. To address whether proliferation is due
to an intracellular or extracellular effect of HIV-1 gene
expression, the conditioned medium collected from HIV-1
transgenic podocytes was added in growth medium of
normal podocytes [8]. Although about fourfold increased
in [3H] thymidine incorporation was observed in HIV-
transgenic podocytes as compared to normal podocytes,
no increased [3H] thymidine uptake was found in the
presence of conditional medium [8]. These data suggest
that the intracellular expression of HIV-1 genes is critical
step for inducing proliferation of podocytes.
CONCLUSION
We present evidence that HIV-1 directly decreases
differentiation markers in podocytes in vitro. Nef was
required and sufficient for the induction of proliferation,
and the down-regulation of some of the genes that are
expressed in mature podocytes. Our data suggest that
Nef is the major candidate of the many HIV-1 gene
products that is responsible for the collapsing glomerulo-
pathy of HIVAN.
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